Over the weekend, Ironwood Pharmaceuticals, Inc. (NASDAQ:I RWD) detailed strong execution against its strategy of building a top-performing commercial biotechnology ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE